Equites Radar

PACS · PACS Group, Inc.

Medical Care FacilitiesUnited StatesAnalyst view: Strong Buy

$44.76

-0.20% last session

End-of-day data · close of 2026-09-11

Mildly bullish3 bullish · 1 bearish technical signals
Consensus: Strong Buy (1.33 from 6 analysts)
To mean target: +31.5%

Market cap

$7B

Enterprise value

$10B

Trailing P/E

26.2

Forward P/E

16.5

Dividend yield

Beta

-0.13

Avg volume

1M

Employees

47K

Daily Change %

-0.20%

5 Days Change

4.94%

10 Days Change

5.41%

30 Days Change

-0.78%

60 Days Change

3.19%

Month to Day Change

5.84%

Year to Day Change

16.18%

Analyst Outlook

Consensus ratingStrong Buy
Recommendation mean (1–5)1.33
Covering analysts6
Mean price target$59.00
Low price target$57.00
Upside to mean target+31.5%

Analyst estimates change daily — follow the shifts on the Estimate Trends page.

Technical Analysis

RSI (14)54.6
50-day MA$44.78
200-day MA$38.22
Price vs 50-day MA-0.0%
Price vs 200-day MA+17.1%
MACD histogram0.15
Volume vs 3-month avg0.7×
52w low $9.6052w high $48.45

Analyst sentiment over time — PACS

Rec Mean (blue, left — higher = more bullish) vs. price targets (right).

Investment Bank Ratings as of 2026-09-04

Latest call per bank · past 12 months

JP Morgan

Overweight

$58.00

+29.3% vs price
▲ raised from $47.00Maintains · 2026-09-04

UBS

Buy

$60.00

+33.8% vs price
▲ raised from $57.00Maintains · 2026-08-06

RBC Capital

Outperform

$57.00

+27.1% vs price
▲ raised from $52.00Maintains · 2026-08-06

Recent rating actions

DateFirmActionRatingPrice target
2026-09-04JP MorganMaintainsOverweight$47.00 $58.00
2026-08-10OppenheimerMaintainsOutperform$48.00 $57.00
2026-08-06UBSMaintainsBuy$57.00 $60.00
2026-08-06RBC CapitalMaintainsOutperform$52.00 $57.00
2026-08-06Truist SecuritiesMaintainsBuy$52.00 $62.00
2026-07-08UBSMaintainsBuy$50.00 $57.00
2026-05-18Truist SecuritiesMaintainsBuy$50.00 $52.00
2026-05-13OppenheimerMaintainsOutperform$42.00 $48.00

Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.

Signal Summary as of 2026-09-11

  • RSI (14): RSI is 55 — neutral momentum, neither overbought nor oversold.
  • Price vs 50-day MA: Trading 0.0% below the 50-day MA ($44.78).
  • Price vs 200-day MA: Trading 17.1% above the 200-day MA ($38.22).
  • MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
  • MACD (12,26,9): MACD histogram is positive (+0.15) — short-term momentum is improving.
  • 52-week range: Price sits between the 52-week low ($9.60) and high ($48.45).

PACS Price Chart

Loading chart for PACS

Fundamentals

Revenue (TTM)$6.0B
EBITDA$0M
Free cash flow$0M
Operating cash flow$1.0B
Book value / share$7.01
Net Debt / EBITDA6.8
WACC2.0%
Revenue growth9.00%
Earnings growth52.00%

About PACS Group, Inc.

PACS Group, Inc., through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. It also provides senior care and independent living facilities. The company engages in the acquisition, ownership, and leasing of health care-related properties. PACS Group, Inc. was founded in 2013 and is headquartered in Salt Lake City, Utah.

More in Medical Care Facilities

Screen PACS against the full market on the Radar →

Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.